SIKs Regulate HDAC7 Stabilization and Cytokine Recall in Late-Stage T Cell Effector Differentiation
The Journal of Immunology · 2023
DOI: 10.4049/jimmunol.2300248 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, 2023. Verfasst von Rachel S Helms und 12 weiteren Autor:innen. Beteiligte Einrichtung: The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Sidney-Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, …. Hauptthemen laut MEDLINE: Cytokines, Protein Processing, Post-Translational, Protein Serine-Threonine Kinases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NCATS NIH HHS, Howard Hughes Medical Institute.
Abstract (Originalsprache)
Understanding the mechanisms underlying the acquisition and maintenance of effector function during T cell differentiation is important to unraveling how these processes can be dysregulated in the context of disease and manipulated for therapeutic intervention. In this study, we report the identification of a previously unappreciated regulator of murine T cell differentiation through the evaluation of a previously unreported activity of the kinase inhibitor, BioE-1197. Specifically, we demonstrate that liver kinase B1 (LKB1)-mediated activation of salt-inducible kinases epigenetically regulates cytokine recall potential in effector CD8+ and Th1 cells. Evaluation of this phenotype revealed that salt-inducible kinase–mediated phosphorylation-dependent stabilization of histone deacetylase 7 (HDAC7) occurred during late-stage effector differentiation. HDAC7 stabilization increased nuclear HDAC7 levels, which correlated with total and cytokine loci-specific reductions in the activating transcription mark histone 3 lysine 27 acetylation (H3K27Ac). Accordingly, HDAC7 stabilization diminished transcriptional induction of cytokine genes upon restimulation. Inhibition of this pathway during differentiation produced effector T cells epigenetically poised for enhanced cytokine recall. This work identifies a previously unrecognized target for enhancing effector T cell functionality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Sidney-Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD.
- Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA.
- Department of Pediatrics, Harvard Medical School, Boston, MA.
- Howard Hughes Medical Institute, Boston, MA.
- Calico Life Sciences LLC, South San Francisco, CA.
- Department of Surgery, University of California San Francisco, San Francisco, CA.
ORCID-Profile: Rachel S Helms, Taekjip Ha, Takashi Tsukamoto, Joel L Pomerantz
Förderung
- NIAID NIH HHS
- NCATS NIH HHS
- Howard Hughes Medical Institute
- NIDDK NIH HHS
- NIBIB NIH HHS
- HHS | NIH | National Institute of Biomedical Imaging and Bioengineering
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Helms, R. S., Marin-Gonzalez, A., Patel, C. H., Sun, I. H., Wen, J., Leone, R. D., Duvall, B., Gao, R. D., Ha, T., Tsukamoto, T., Slusher, B. S., Pomerantz, J. L., & Powell, J. D. (2023). SIKs Regulate HDAC7 Stabilization and Cytokine Recall in Late-Stage T Cell Effector Differentiation. The Journal of Immunology. https://doi.org/10.4049/jimmunol.2300248
Vancouver
Helms RS, Marin-Gonzalez A, Patel CH, Sun IH, Wen J, Leone RD, et al. SIKs Regulate HDAC7 Stabilization and Cytokine Recall in Late-Stage T Cell Effector Differentiation. The Journal of Immunology. 2023. doi:10.4049/jimmunol.2300248
BibTeX
@article{Helms2023,
author = {Helms, Rachel S and Marin-Gonzalez, Alberto and Patel, Chirag H and Sun, Im-Hong and Wen, Jiayu and Leone, Robert D and Duvall, Bridget and Gao, Run-Duo and Ha, Taekjip and Tsukamoto, Takashi and Slusher, Barbara S and Pomerantz, Joel L and Powell, Jonathan D},
title = {SIKs Regulate HDAC7 Stabilization and Cytokine Recall in Late-Stage T Cell Effector Differentiation},
journal = {The Journal of Immunology},
year = {2023},
doi = {10.4049/jimmunol.2300248}
}
EUVIMED